PRWeb 2015-08-03 Immune Therapeutics Inc., a U.S. public company [OTC:BB IMUN] in partnership with GB Pharma Holdings Inc and American Hospitals... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=431984
/PRNewswire/ -- Ovarian Cancer Therapies - Explore Potentials of New Drugs, Industry Changes and Emerging Opportunities What's the future for... ...http://in.advfn.com/p.php?pid=nmona&article=67995829
CryoPort, Inc. (NASDAQ:CYRX) Intraday Stock Chart Today : Monday 3 August 2015 LAKE FOREST, Calif. , Aug. 3, 2015 /PRNewswire/ -- Cryoport,... ...http://in.advfn.com/p.php?pid=nmona&article=67994944
Orgenesis Inc., a cell therapy and regenerative medicine company, announced that its wholly owned subsidiary, MaSTherCell, a contract development... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=89797&sid=2
By By | Reuters By Ben Hirschler LONDON (Reuters) - New cancer drug cocktails set to reach the market in the next few years will test the... ...https://in.news.yahoo.com/cocktails-test-limits-cancer-drug-pricing-040307636--finance.html
CANCER HEALER CENTER is a cancer...